BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/07/2026

FDA Classifies Diabetes Digital Behavioral Therapeutic Device into Class II with Special Controls

The FDA has classified the diabetes digital behavioral therapeutic device into Class II, a category that requires special controls to ensure safety and effectiveness, aiming to enhance patients' access to innovative devices while reducing regulatory burdens.

Source: Federal Register — Health and Human ServicesOpen original release →